No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors

No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors

Abstract Background IgG-class autoantibodies to N-Methyl-D-Aspartate (NMDA)-type glutamate receptors define a novel entity of autoimmune encephalitis. Studies examining the prevalence of NMDA IgA/IgM antibodies in patients with Parkinson disease with/without dementia produced conflicting results. We...

Full description

Bibliographic Details
Main Authors: Franziska Hopfner, Stefanie H. Müller, Dagmar Steppat, Joanna Miller, Nele Schmidt, Klaus-Peter Wandinger, Frank Leypoldt, Daniela Berg, Andre Franke, Wolfgang Lieb, Lukas Tittmann, Monika Balzer-Geldsetzer, Simon Baudrexel, Richard Dodel, Ruediger Hilker-Roggendorf, Elke Kalbe, Jan Kassubek, Thomas Klockgether, Inga Liepelt-Scarfone, Brit Mollenhauer, Petra Neuser, Kathrin Reetz, Oliver Riedel, Claudia Schulte, Jörg B. Schulz, Annika Spottke, Alexander Storch, Claudia Trenkwalder, Hans-Ulrich Wittchen, Karsten Witt, Ullrich Wüllner, Günther Deuschl, Gregor Kuhlenbäumer
Format: Article
Language:English
Published: BMC 2019-04-01
Series:Translational Neurodegeneration
Subjects:
NMDA antibody
NMDA IgA/IgM antibodies
Parkinson disease
Cognitive impairment
Online Access:http://link.springer.com/article/10.1186/s40035-019-0153-0

Internet

http://link.springer.com/article/10.1186/s40035-019-0153-0

Similar Items